Public opinions about overdiagnosis: A national community survey

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Moynihan, Ray ^a   Nickel, Brooke ^b   Hersch, Jolyn ^b   Beller, Elaine ^a   Doust, Jenny ^a   Compton, Shane ^c   Barratt, Alexandra ^b   Bero, Lisa ^d   McCaffery, Kirsten ^b  

^a BOND UNIVERSITY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c The Social Research Centre   (Australia)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIAN; BREAST CANCER; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSIS; DISEASE CLASSIFICATION; DRUG INDUSTRY; FEMALE; HUMAN; MALE; MAMMOGRAPHY; OVERDIAGNOSIS; PROSTATE CANCER; PUBLIC OPINION; QUESTIONNAIRE; TELEPHONE INTERVIEW; ATTITUDE TO HEALTH; AUSTRALIA; CONFLICT OF INTEREST; HEALTH SERVICE; INTERVIEW; PHYSICIAN ATTITUDE; STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS;

ATTITUDE TO HEALTH; AUSTRALIA; CONFLICT OF INTEREST; DRUG INDUSTRY; FEMALE; HUMANS; INTERVIEWS AS TOPIC; MALE; MEDICAL OVERUSE; PHYSICIAN'S ROLE; PUBLIC OPINION; SURVEYS AND QUESTIONNAIRES;

EID: 84930667582     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125165     Document Type: Article

References (32)

1. Hoffman JR, Cooper RJ. Overdiagnosis of disease: a modern epidemic. Arch Intern Med. 2012; 172: 1123-1124. doi: 10.1001/archinternmed.2012.3319 PMID: 22733387
2. Welch HG, Schwartz LM, Woloshin S. Overdiagnosed: making people sick in the pursuit of health. Boston: Beacon Press; 2011.
3. Moynihan R, Henry D, Moons KGM. Using Evidence to Combat Overdiagnosis and Overtreatment: Evaluating Treatments, Tests, and Disease Definitions in the Time of Too Much. PLoS Med. 2014; 11(7): e1001655. doi: 10.1371/journal.pmed.1001655 PMID: 24983872
4. Moynihan R, Doust J, Henry D. Preventing overdiagnosis: how to stop harming the healthy. BMJ 2012: 344: e3502. doi: 10.1136/bmj.e3502 PMID: 22645185
5. Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening: an independent review. Lancet 2012; 380: 1778-1786 doi: 10.1016/S0140-6736(12)61611-0 PMID: 23117178
6. Moyer VA, on behalf of the U.S. Preventive Services Task Force. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2012; 157: 120-134. doi: 10.7326/0003-4819-157-2-201207170-00459 PMID: 22801674
7. Carter JL, Coletti RJ, Harris RP. Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods. BMJ 2015; 350: g7773. doi: 10.1136/bmj.g7773 PMID: 25569206
8. Ciatto S. The overdiagnosis nightmare: a time for caution. BMC Women's Health 2009; 9: 34. doi: 10.1186/1472-6874-9-34 PMID: 20015373
9. Esserman L, Thompson I, Reid B. Overdiagnosis and Overtreatment in Cancer: An Opportunity for Improvement. JAMA 2013; 310(8): 797-8. PMID: 23896967
10. Clarke AE, Shim JK, Mamo L, Fosket JR, Fishman JR. Biomedicalization: Technoscientific Transformations of Health, Illness, and U.S. Biomedicine. American Sociological Review 2003; 68,(2); 161-194
11. Armstrong D. The rise of surveillance medicine. Sociol Health Illn. 1995; 17: 393-404.
12. Brito JP, Morris JC, Montori VM. Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumours. BMJ 2013; 347: f4706. doi: 10.1136/bmj.f4706 PMID: 23982465
13. Cundy T. Ackerman E, Ryan E. Gestational diabetes: new criteria may triple the prevalence but effect on outcomes is unclear. BMJ 2014; 348: g1567. doi: 10.1136/bmj.g1567 PMID: 24618099
14. Wiener RS, Schwartz LM, Woloshin S. When a test is too good: how CT pulmonary angiograms find pulmonary emboli that do not need to be found BMJ 2013; 346: f3368.
15. Moynihan RN, Cooke GP, Doust JA, Bero L, Hill S, Glasziou P. Expanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United States. PLoS Med. 2013; 10: e1001500. doi: 10.1371/journal.pmed.1001500 PMID: 23966841
16. IOM (Institute of Medicine). Clinical practice guidelines we can trust. Washington (D.C.): The National Academies Press; 2011. PMID: 24983061
17. Schwartz LM, Woloshin S, Fowler FJ, Welch HG. Enthusiasm for Cancer Screening in the United States. JAMA 2004; 291: 71-78. PMID: 14709578
18. Hersch J, Jansen J, Barratt A, Irwig L, Houssami N, Howard K, et al. Women's views on overdiagnosis in breast cancer screening: a qualitative study. BMJ 2013; 346: f158. doi: 10.1136/bmj.f158 PMID: 23344309
19. Wegwarth O, Gigerenzer G. Overdiagnosis and Overtreatment: Evaluation of What Physicians Tell Their Patients About Screening Harms. JAMA Int Med. 2013; Published online October 21
20. Weinfurt KP, Hall MA, King NMP, Friedman JY, Schulman KA, Sugarman J. Disclosure of Financial Relationships to Participants in Clinical Research.NEJM 2009; 361: 916-921 doi: 10.1056/NEJMsb0902598 PMID: 19710491
21. Holbrook A, Lexchin J, Pullenayegum E, Campbell C, Marlow B, Troyan S, et al. What do Canadians think about physician-pharmaceutical industry interactions? Health Policy 2013; 112(3):255-63. doi: 10.1016/j.healthpol.2013.04.020. Epub 2013 May 24. PMID: 23711633
22. Savard J. How genetic testing is swelling the ranks of the 'worried well.' The Conversation. September 13 2012 Available: https://theconversation.com/how-genetic-testing-is-swelling-the-ranks-of-theworried-well-9080
23. Sheridan SL, Vu MB, Sutkowi AT, Brewer NT, DeFrank J, Barclay C, et al. Patient's reasons for pursuing diagnosis of harmless and untreatable diseases: insights on overdiagnosis. Abstract presented and published at Preventing Overdiagnosis conference, Dartmouth College, US, September 10-12, 2013
24. th edition. AAPOR;2011. Available: http://www.aapor.org/AAPORKentico/AAPOR-Main/media/MainSiteFiles/StandardDefinitions2011-1.pdf
25. Australian Bureau of Statistics. Estimated Resident Population. Catalog number 3101.0. 2012
26. Australian Bureau of Statistics. Census Table Builder (QALLP-1 by AGEP).2011
27. Wilson A, Bonevski B, Jones A, Henry D. Media Reporting of Health Interventions: Signs of Improvement, but Major Problems Persist. PLoS ONE 2009; 4(3): e4831. doi: 10.1371/journal.pone.0004831 PMID: 19293924
28. Barratt A, Cockburn J, Smith D, et al. Reliability and validity of women's recall of mammographic screening. Aust NZ J Public Health. 2000; 24: 79-81.
29. The Pew Research Centre. Assessing the Representativeness of Public Opinion Surveys, May 15 2012. Available: http://www.people-press.org/2012/05/15/assessing-the-representativeness-of-publicopinion-surveys/30. Commonwealth of Australia (Australian Communications and Media Authority) Communications Report, 2012-2013:p19.
30. Blumberg SJ, Luke JV. Wireless Substitution: Early Release of Estimates From the National Health Interview Survey. Centre for Disease Control and Prevention, Division of Health Interview Statistics, National Centre for Health Statistics. July-December 2012. Available: http://www.cdc.gov/nchs/data/nhis/earlyrelease/wireless201306.pdf
31. Davey HM, Barratt AL, Davey E, Butow PN, Redman S, Houssami N, et al. Medical tests: women's reported and preferred decision-making roles and preferences for information on benefits, side-effects and false results. Health Expectations 2002; 5: 330-340. PMID: 12460222
32. Waller J, Whitaker KL, Winstanley K, Power E, Wardle J. A survey study of women's responses to information about overdiagnosis in breast cancer screening in Britain. Br J Cancer. 2014; 111(9):1831-5. doi: 10.1038/bjc.2014.482 PMID: 25167224